Toujeo is the new basal insulin from Sanofi. It’s not quite a replacement for Lantus as Sanofi will continue to sell Lan…
Toujeo
Sanofi’s New Basal Insulin (Toujeo) Approved by EU
The European Commission has granted Sanofi marketing authorization in Europe for Toujeo (insulin glargine [rDNA origin] …
FDA Approves Toujeo, Sanofi’s New Long Acting Insulin
The U.S. Food and Drug Administration (FDA) approved Sanofi’s new once daily long acting insulin, Toujeo (insulin glargi…
FDA Accepts Sanofi’s NDA for New Basal Insulin, Toujeo
The U.S. Food and Drug Administration (FDA) has accepted for review Sanofi’s New Drug Application (NDA) for Toujeo (insu…
